SOUTH TEXAS BLOOD & TISSUE CENTER
- SAN ANTONIO, TX 78201-2023
- Corporate Entity (Tax Exempt)
- SAM expiring
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $7.5M
- Awards on record
- 10
- Contract vehicles
- 0
- Verified credentials
- 0
SAM.gov registration expires in 10 days
SOUTH TEXAS BLOOD & TISSUE CENTER’s registration expires on Nov 24, 2026. Renewal can take weeks; confirm it stays active through proposal submission and award.
View on SAM.gov (opens in a new tab)Learn more about SAM registration and the UEI
About SOUTH TEXAS BLOOD & TISSUE CENTER
- Headquarters
- SAN ANTONIO, TX 78201-2023
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIJ4UKR8JY4L54
- CAGE082Q3
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $7.5M
- Awards on record
- 10
- Top funding agencies
- Department of the Army · Department of Veterans Affairs
Awards
W81K0026FA052
Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)IN ACCORDANCE WITH FAR SUBPART 16.4, THE GOVERNMENT IS ISSUING A DELIVERY ORDER TO ACQUIRE SUPPLIES FOR BLOOD PRODUCTS UNDER CONTRACT…
Department of Defense · Department of the Army
- Obligated
- $0
- Period of performance
- Oct 1, 2026 – Sep 30, 2027
36C25726N0185
Recompete < 6 mo: Potential end Feb 15, 2027 (3 months away)BLOOD AND BLOOD PRODUCTS ORDERING PERIOD 5
Department of Veterans Affairs
- Obligated
- $743.2K
- Period of performance
- Feb 16, 2026 – Feb 15, 2027
W81K0025FA137
Completed: Period of performance ended Sep 30, 2026IN ACCORDANCE WITH FAR SUBPART 16.4, THE GOVERNMENT IS UNILATERALLY ISSUING THIS DELIVERY ORDER TO ACQUIRE SUPPLIES FOR BLOOD PRODUCTS…
Department of Defense · Department of the Army
- Obligated
- $2.2M
- Period of performance
- Oct 1, 2025 – Sep 30, 2026
36C25725N0112
Completed: Period of performance ended Feb 15, 2026BLOOD AND BLOOD PRODUCTS
Department of Veterans Affairs
- Obligated
- $743.2K
- Period of performance
- Feb 16, 2025 – Feb 15, 2026
W81K0024F0129
Completed: Period of performance ended Sep 30, 2025BLOOD PRODUCTS
Department of Defense · Department of the Army
- Obligated
- $1.7M
- Period of performance
- Oct 1, 2024 – Sep 30, 2025
36C25724N0083
Completed: Period of performance ended Feb 15, 2025BLOOD AND BLOOD PRODUCTS
Department of Veterans Affairs
- Obligated
- $387.9K
- Period of performance
- Feb 16, 2024 – Feb 15, 2025
W81K0023F0206
Completed: Period of performance ended Sep 30, 2024SEVEN (7) DAY PLATELET CONCENTRATE - BLOOD PRODUCTS AND BLOOD COMPONENTS
Department of Defense · Department of the Army
- Obligated
- $1.3M
- Period of performance
- Oct 1, 2023 – Sep 30, 2024
W81K0024P0095
Completed: Period of performance ended Jul 3, 2024IMPORTED BLOOD COM - UNAUTHORIZED COMMITMENT
Department of Defense · Department of the Army
- Obligated
- $79.9K
- Period of performance
- May 16, 2024 – Jul 3, 2024
36C25723N0096
Completed: Period of performance ended Feb 15, 2024BLOOD AND BLOOD PRODUCTS
Department of Veterans Affairs
- Obligated
- $393.7K
- Period of performance
- Feb 16, 2023 – Feb 15, 2024
W81K0018P0426
Completed: Period of performance ended Sep 30, 2023BLOOD PRODUCTS / COMPONENTS
Department of Defense · Department of the Army
- Obligated
- $1.6M
- Period of performance
- Oct 1, 2018 – Sep 30, 2023
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
W81K0026FA052 under W81K0023D0009 IN ACCORDANCE WITH FAR SUBPART 16.4, THE GOVERNMENT IS ISSUING A DELIVERY ORDER TO ACQUIRE SUPPLIES FOR BLOOD PRODUCTS UNDER CONTRACT… | Department of Defense · Department of the Army | 621991 · 6505DRUGS AND BIOLOGICALS | $0 | Oct 1, 2026 – Sep 30, 2027 | Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)AI brief for award W81K0026FA052Bid team for the recompete of award W81K0026FA052 |
36C25726N0185 under 36C25722D0035 BLOOD AND BLOOD PRODUCTS ORDERING PERIOD 5 | Department of Veterans Affairs | 325414 · 6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $743.2K | Feb 16, 2026 – Feb 15, 2027 | Recompete < 6 mo: Potential end Feb 15, 2027 (3 months away)AI brief for award 36C25726N0185Bid team for the recompete of award 36C25726N0185 |
W81K0025FA137 under W81K0023D0009 IN ACCORDANCE WITH FAR SUBPART 16.4, THE GOVERNMENT IS UNILATERALLY ISSUING THIS DELIVERY ORDER TO ACQUIRE SUPPLIES FOR BLOOD PRODUCTS… | Department of Defense · Department of the Army | 621991 · 6505DRUGS AND BIOLOGICALS | $2.2M | Oct 1, 2025 – Sep 30, 2026 | Completed: Period of performance ended Sep 30, 2026 |
36C25725N0112 under 36C25722D0035 BLOOD AND BLOOD PRODUCTS | Department of Veterans Affairs | 325414 · 6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $743.2K | Feb 16, 2025 – Feb 15, 2026 | Completed: Period of performance ended Feb 15, 2026 |
W81K0024F0129 under W81K0023D0009 BLOOD PRODUCTS | Department of Defense · Department of the Army | 621991 · 6505DRUGS AND BIOLOGICALS | $1.7M | Oct 1, 2024 – Sep 30, 2025 | Completed: Period of performance ended Sep 30, 2025 |
36C25724N0083 under 36C25722D0035 BLOOD AND BLOOD PRODUCTS | Department of Veterans Affairs | 325414 · 6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $387.9K | Feb 16, 2024 – Feb 15, 2025 | Completed: Period of performance ended Feb 15, 2025 |
W81K0023F0206 under W81K0023D0009 SEVEN (7) DAY PLATELET CONCENTRATE - BLOOD PRODUCTS AND BLOOD COMPONENTS | Department of Defense · Department of the Army | 621991 · 6505DRUGS AND BIOLOGICALS | $1.3M | Oct 1, 2023 – Sep 30, 2024 | Completed: Period of performance ended Sep 30, 2024 |
W81K0024P0095 IMPORTED BLOOD COM - UNAUTHORIZED COMMITMENT | Department of Defense · Department of the Army | 621991 · 6505DRUGS AND BIOLOGICALS | $79.9K | May 16, 2024 – Jul 3, 2024 | Completed: Period of performance ended Jul 3, 2024 |
36C25723N0096 under 36C25722D0035 BLOOD AND BLOOD PRODUCTS | Department of Veterans Affairs | 325414 · 6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $393.7K | Feb 16, 2023 – Feb 15, 2024 | Completed: Period of performance ended Feb 15, 2024 |
W81K0018P0426 BLOOD PRODUCTS / COMPONENTS | Department of Defense · Department of the Army | 621991 · 6505DRUGS AND BIOLOGICALS | $1.6M | Oct 1, 2018 – Sep 30, 2023 | Completed: Period of performance ended Sep 30, 2023 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
No SBIR/STTR awards on record
Source: SBIR.gov award records (opens in a new tab) · sync date not recorded
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 621991Title not in the curated listPrimary
SAM.gov does not report this entity as small under any listed NAICS code.
Socio-economic status
No socio-economic certifications reported in SAM.gov.
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with SOUTH TEXAS BLOOD & TISSUE CENTER?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
